Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dose-finding cross-over study of lorediplon in adult insomnia disorder
2014-001966-87Phase 2Completed
- Sponsor
- Ferrer
- Start
- Jan 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of lorediplon in Insomnia (2 arms), sponsored by Ferrer. Primary endpoint: Wake after Sleep Onset (WASO) change from baseline. Started Jan 2015; status: completed.
02
Drugs
lorediplon
03
Conditions
Insomnia
Beyond the preview
Go deeper on 2014-001966-87.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2014-001966-87.